Literature DB >> 31008635

Preventive cognitive therapy versus care as usual in cognitive behavioral therapy responders: A randomized controlled trial.

Margo de Jonge1, Claudi L H Bockting2, Martijn J Kikkert1, Maarten K van Dijk3, Digna J F van Schaik4, Jaap Peen1, Steven D Hollon5, Jack J M Dekker1.   

Abstract

OBJECTIVE: The optimization of long-term outcomes is an important goal in the treatment of major depressive disorder. Offering subsequent preventive cognitive therapy (PCT) to patients who responded to acute cognitive behavioral therapy (CBT) may reduce the risk of relapse/recurrence.
METHOD: Therefore, a multicenter randomized controlled trial was conducted comparing the addition of eight weekly sessions of PCT to care as usual (CAU) versus CAU alone in patients with a history of depression in remission following treatment with CBT. A total of 214 recurrently depressed patients who remitted following treatment with CBT were randomized to PCT (n = 107) or CAU (n = 107). Primary outcome was time to relapse/recurrence over 15 months and was assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Secondary outcomes were depressive symptoms measured by the Inventory of Depressive Symptomatology-Self Report and number and severity of relapses/recurrences measured by the SCID-I.
RESULTS: Over the 15-month follow-up, the addition of PCT significantly delayed time to relapse/recurrence relative to CAU alone, hazard ratio = 1.807 (number needed to treat = 8.1), p = .02, 95% CI [1.029, 3.174]. No significant differences were found between the conditions on number or severity of relapses/recurrences and residual symptoms.
CONCLUSION: Adding PCT was significantly more effective than CAU alone in delaying time to relapse/recurrence of depression over a period of 15 months among CBT responders. After response on CBT, therapists should consider providing PCT to recurrently depressed patients. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 31008635     DOI: 10.1037/ccp0000395

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  3 in total

1.  Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trial.

Authors:  Claudi Bockting; Amanda M Legemaat; Johanne G J van der Stappen; Gert J Geurtsen; Maria Semkovska; Huibert Burger; Isidoor O Bergfeld; Nicoline Lous; Damiaan A J P Denys; Marlies Brouwer
Journal:  BMJ Open       Date:  2022-06-23       Impact factor: 3.006

2.  Neurocognitive working mechanisms of the prevention of relapse in remitted recurrent depression (NEWPRIDE): protocol of a randomized controlled neuroimaging trial of preventive cognitive therapy.

Authors:  Rozemarijn S van Kleef; Claudi L H Bockting; Evelien van Valen; André Aleman; Jan-Bernard C Marsman; Marie-José van Tol
Journal:  BMC Psychiatry       Date:  2019-12-19       Impact factor: 3.630

3.  Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis.

Authors:  Esther Krijnen-de Bruin; Willemijn Scholten; Anna Muntingh; Otto Maarsingh; Berno van Meijel; Annemieke van Straten; Neeltje Batelaan
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.